The Impact of Obesity on the Rise in Esophageal Adenocarcinoma Incidence: Estimates from a Disease Simulation Model

被引:28
作者
Kong, Chung Yin [1 ,3 ]
Nattinger, Kevin J. [1 ,2 ]
Hayeck, Tristan J. [1 ,2 ]
Omer, Zehra B. [2 ]
Wang, Y. Claire [5 ]
Spechler, Stuart J. [6 ]
McMahon, Pamela M. [1 ,3 ]
Gazelle, G. Scott [1 ,3 ,4 ]
Hur, Chin [1 ,2 ,3 ]
机构
[1] Massachusetts Gen Hosp, Inst Technol Assessment, Boston, MA 02114 USA
[2] Massachusetts Gen Hosp, Gastrointestinal Unit, Boston, MA 02114 USA
[3] Harvard Univ, Sch Med, Boston, MA USA
[4] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA
[5] Columbia Univ, Mailman Sch Publ Hlth, New York, NY USA
[6] VA N Texas Hlth Care Syst, Dallas, TX USA
关键词
GASTROESOPHAGEAL-REFLUX DISEASE; BODY-MASS INDEX; BARRETTS-ESOPHAGUS; GASTRIC CARDIA; ABDOMINAL OBESITY; UNITED-STATES; CLINICAL SPECTRUM; ACID REFLUX; POPULATION; PREVALENCE;
D O I
10.1158/1055-9965.EPI-11-0547
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: The United States has experienced an alarming and unexplained increase in the incidence of esophageal adenocarcinoma (EAC) since the 1970s. A concurrent increase in obesity has led some to suggest a relationship between the two trends. We explore the extent of this relationship. Methods: Using a previously validated disease simulation model of white males in the United States, we estimated EAC incidence 1973 to 2005 given constant obesity prevalence and low population progression rates consistent with the early 1970s. Introducing only the observed, rising obesity prevalence, we calculated the incremental incidence caused by obesity. We compared these with EAC incidence data from the National Cancer Institute's Surveillance, Epidemiology, and End Results (SEER) registry to determine obesity's contribution to the rise therein. Incidences were converted to absolute numbers of cases using U. S. population data. Results: Using constant obesity prevalence, we projected a total of 30,555 EAC cases cumulatively over 1973 to 2005 and 1,151 in 2005 alone. Incorporating the observed obesity trend resulted in 35,767 cumulative EACs and 1,608 in 2005. Estimates derived from SEER data showed 111,223 cumulative and 7,173 cases in 2005. We conclude that the rise in obesity accounted for 6.5% of the increase in EAC cases that occurred from 1973 to 2005 and 7.6% in the year 2005. Conclusion: Using published OR for EAC among obese individuals, we found that only a small percentage of the rise in EAC incidence is attributable to secular trends in obesity. Impact: Other factors, alone and in combination, should be explored as causes of the EAC epidemic. Cancer Epidemiol Biomarkers Prev; 20(11); 2450-6. (C) 2011 AACR.
引用
收藏
页码:2450 / 2456
页数:7
相关论文
共 62 条
[1]  
Abrams JA, CANC EPIDEMIOL BIOMA, V20, P183
[2]   Visceral obesity and the risk of Barrett's esophagus in Japanese patients with non-alcoholic fatty liver disease [J].
Akiyama, Tomoyuki ;
Yoneda, Masato ;
Inamori, Masahiko ;
Iida, Hiroshi ;
Endo, Hiroki ;
Hosono, Kunihiro ;
Yoneda, Kyoko ;
Fujita, Koji ;
Koide, Tomoko ;
Tokoro, Chikako ;
Takahashi, Hirokazu ;
Goto, Ayumu ;
Abe, Yasunobu ;
Kirikoshi, Hiroyuki ;
Kobayashi, Noritoshi ;
Kubota, Kensuke ;
Saito, Satoru ;
Nakajima, Atsushi .
BMC GASTROENTEROLOGY, 2009, 9
[3]   Effect of screening and adjuvant therapy on mortality from breast cancer [J].
Berry, DA ;
Cronin, KA ;
Plevritis, SK ;
Fryback, DG ;
Clarke, L ;
Zelen, M ;
Mandelblatt, JS ;
Yakovlev, AY ;
Habbema, JDF ;
Feuer, EJ .
NEW ENGLAND JOURNAL OF MEDICINE, 2005, 353 (17) :1784-1792
[4]  
Bollschweiler E, 2001, CANCER, V92, P549, DOI 10.1002/1097-0142(20010801)92:3<549::AID-CNCR1354>3.0.CO
[5]  
2-L
[6]  
BROWN LM, 1995, J NATL CANCER I, V87, P104, DOI 10.1093/jnci/87.2.104
[7]   BARRETTS-ESOPHAGUS - AGE, PREVALENCE, AND EXTENT OF COLUMNAR EPITHELIUM [J].
CAMERON, AJ ;
LOMBOY, CT .
GASTROENTEROLOGY, 1992, 103 (04) :1241-1245
[8]   Prevalence, clinical spectrum and atypical symptoms of gastro-oesophageal reflux in Argentina: a nationwide population-based study [J].
Chiocca, JC ;
Olmos, JA ;
Salis, GB ;
Soifer, LO ;
Higa, R ;
Marcolongo, M .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2005, 22 (04) :331-342
[9]   Body mass index and risk of adenocarcinomas of the esophagus and gastric cardia [J].
Chow, WH ;
Blot, WJ ;
Vaughn, TL ;
Risch, HA ;
Gammon, MD ;
Stanford, JL ;
Dubrow, R ;
Schoenberg, JB ;
Mayne, ST ;
Farrow, DC ;
Ahsan, H ;
West, AB ;
Rotterdam, H ;
Niwa, S ;
Fraumeni, JF .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1998, 90 (02) :150-155
[10]  
Clark G W, 1997, J Gastrointest Surg, V1, P113